<!DOCTYPE html><html lang="en-us" >


<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  
  
  
    <meta name="generator" content="Wowchemy 5.5.0 for Hugo" />
  

  
  










  







  
  
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin />
  

  
  
  
    
      
      <link rel="preload" as="style" href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap">
      <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap" media="print" onload="this.media='all'">
    
  

  
  
  
  
  
    
    
    
  
  

  <meta name="author" content="H. Gregg Claycamp" />

  
  
  
    
  
  <meta name="description" content="Quality risk management for the pharmaceutical industry was recently defined in internationally harmonized guidance as a systematic process for the assessment, control, communication, and review of risks to the quality of the drug product across the product life cycle. Two overarching principles for quality risk  management are that evaluations of risk should be scientifically based and ultimately linked to risk to the patient, and the level of effort and documentation of quality risk management processes should be commensurate with the level of risk. Numerous tools for risk management come from other applied sciences and manufacturing having a longer history of risk management. The degree of quantitative sophistication among tools varies from generalized and qualitative, “high-level” tools to computationally rigorous, “low-level,” quantitative tools. Risk is described in recent guidance as a combination of the probability of occurrence of harm and the severity of that harm. Risk management always comes with uncertainty, given that it calls for  projections of the likelihood of adverse events for given severities. As a relatively new application of risk management, quality risk management can benefit from adapting existing theory and practice to pharmaceutical manufacturing." />

  
  <link rel="alternate" hreflang="en-us" href="https://www.gclaycamp.com/publication/2007-perspective-on-qrm/" />

  
  
  
    <meta name="theme-color" content="#1565c0" />
  

  
  

  

  <link rel="stylesheet" href="/css/vendor-bundle.min.c7b8d9abd591ba2253ea42747e3ac3f5.css" media="print" onload="this.media='all'">

  
  
  
    
    

    
    
    
    
      
      
    
    
    

    
    
    
    

    
    
    

    

    
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      
        
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
  

  
  
  
  
  
  <link rel="stylesheet" href="/css/wowchemy.79171b649d6fea55e35d07da5e008fbe.css" />

  



  


  


  




  
  
  

  

  
    <link rel="manifest" href="/manifest.webmanifest" />
  

  <link rel="icon" type="image/png" href="/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_32x32_fill_lanczos_center_3.png" />
  <link rel="apple-touch-icon" type="image/png" href="/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_180x180_fill_lanczos_center_3.png" />

  <link rel="canonical" href="https://www.gclaycamp.com/publication/2007-perspective-on-qrm/" />

  
  
  
  
  
  
  
  
    
    
  
  

  
  
    
    
  
  <meta property="twitter:card" content="summary" />
  
  <meta property="og:site_name" content="Gregg Claycamp" />
  <meta property="og:url" content="https://www.gclaycamp.com/publication/2007-perspective-on-qrm/" />
  <meta property="og:title" content="Perspective on Quality Risk Management of Pharmaceutical Quality | Gregg Claycamp" />
  <meta property="og:description" content="Quality risk management for the pharmaceutical industry was recently defined in internationally harmonized guidance as a systematic process for the assessment, control, communication, and review of risks to the quality of the drug product across the product life cycle. Two overarching principles for quality risk  management are that evaluations of risk should be scientifically based and ultimately linked to risk to the patient, and the level of effort and documentation of quality risk management processes should be commensurate with the level of risk. Numerous tools for risk management come from other applied sciences and manufacturing having a longer history of risk management. The degree of quantitative sophistication among tools varies from generalized and qualitative, “high-level” tools to computationally rigorous, “low-level,” quantitative tools. Risk is described in recent guidance as a combination of the probability of occurrence of harm and the severity of that harm. Risk management always comes with uncertainty, given that it calls for  projections of the likelihood of adverse events for given severities. As a relatively new application of risk management, quality risk management can benefit from adapting existing theory and practice to pharmaceutical manufacturing." /><meta property="og:image" content="https://www.gclaycamp.com/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_3.png" />
    <meta property="twitter:image" content="https://www.gclaycamp.com/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_3.png" /><meta property="og:locale" content="en-us" />
  
    
      <meta
        property="article:published_time"
        content="2007-09-01T00:00:00&#43;00:00"
      />
    
    <meta property="article:modified_time" content="2021-06-02T09:54:29-05:00">
  

  


    









<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://www.gclaycamp.com/publication/2007-perspective-on-qrm/"
  },
  "headline": "Perspective on Quality Risk Management of Pharmaceutical Quality",
  
  "datePublished": "2007-09-01T00:00:00Z",
  "dateModified": "2021-06-02T09:54:29-05:00",
  
  "author": {
    "@type": "Person",
    "name": "H. Gregg Claycamp"
  },
  
  "publisher": {
    "@type": "Organization",
    "name": "Gregg Claycamp",
    "logo": {
      "@type": "ImageObject",
      "url": "https://www.gclaycamp.com/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_192x192_fill_lanczos_center_3.png"
    }
  },
  "description": "Quality risk management for the pharmaceutical industry was recently defined in internationally harmonized guidance as a systematic process for the assessment, control, communication, and review of risks to the quality of the drug product across the product life cycle. Two overarching principles for quality risk  management are that evaluations of risk should be scientifically based and ultimately linked to risk to the patient, and the level of effort and documentation of quality risk management processes should be commensurate with the level of risk. Numerous tools for risk management come from other applied sciences and manufacturing having a longer history of risk management. The degree of quantitative sophistication among tools varies from generalized and qualitative, “high-level” tools to computationally rigorous, “low-level,” quantitative tools. Risk is described in recent guidance as a combination of the probability of occurrence of harm and the severity of that harm. Risk management always comes with uncertainty, given that it calls for  projections of the likelihood of adverse events for given severities. As a relatively new application of risk management, quality risk management can benefit from adapting existing theory and practice to pharmaceutical manufacturing."
}
</script>

  

  

  

  





  <title>Perspective on Quality Risk Management of Pharmaceutical Quality | Gregg Claycamp</title>
</head>


<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" class="page-wrapper   " data-wc-page-id="dc092b0c3f4900a1b9318d77364f761f" >

  
  
  
  
  
  
  
  
  
  <script src="/js/wowchemy-init.min.2ed908358299dd7ab553faae685c746c.js"></script>

  




  <div class="page-header">
    
<nav class="navbar navbar-light fixed-top navbar-expand-lg py-0" id="navbar-main">
  <div class="container">

    
      <a class="navbar-brand" href="/">Gregg Claycamp</a>
      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
        <span><i class="fas fa-bars"></i></span>
      </button>
      

    
    <div class="collapse navbar-collapse" id="navbar">

      
      
      <ul class="navbar-nav ml-auto">
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#about"><span>About</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#posts"><span>Posts</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#projects"><span>Projects</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#featured"><span>Publications</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#talks"><span>Talks</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#contact"><span>Contact</span></a>
        </li>

        
        

      

        

        

        

        

      </ul>

    </div>
  </div>
</nav>

  </div>

  <div class="page-body">
    
    
    

    








<div class="pub">

  












  

  
  
  
<div class="article-container pt-3">
  <h1>Perspective on Quality Risk Management of Pharmaceutical Quality</h1>

  

  
    


<div class="article-metadata">

  
  
  
  
  <div>
    

  <span >
      <a href="/author/h.-gregg-claycamp/">H. Gregg Claycamp</a></span>
  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    September 2007
  </span>
  

  

  

  
  
  
  

  
  
  <span class="middot-divider"></span>
  <span class="article-categories">
    <i class="fas fa-folder mr-1"></i><a href="/category/quality-risk-management/">Quality Risk Management</a></span>
  

</div>

    




<div class="btn-links mb-3">
  
  








  
    
  



<a class="btn btn-outline-primary btn-page-header" href="/pdf/Claycamp-DIA.pdf" target="_blank" rel="noopener">
  PDF
</a>



<a href="#" class="btn btn-outline-primary btn-page-header js-cite-modal"
        data-filename="/publication/2007-perspective-on-qrm/cite.bib">
  Cite
</a>















</div>


  
</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract">Quality risk management for the pharmaceutical industry was recently defined in internationally harmonized guidance as a systematic process for the assessment, control, communication, and review of risks to the quality of the drug product across the product life cycle. Two overarching principles for quality risk  management are that evaluations of risk should be scientifically based and ultimately linked to risk to the patient, and the level of effort and documentation of quality risk management processes should be commensurate with the level of risk. Numerous tools for risk management come from other applied sciences and manufacturing having a longer history of risk management. The degree of quantitative sophistication among tools varies from generalized and qualitative, “high-level” tools to computationally rigorous, “low-level,” quantitative tools. Risk is described in recent guidance as a combination of the probability of occurrence of harm and the severity of that harm. Risk management always comes with uncertainty, given that it calls for  projections of the likelihood of adverse events for given severities. As a relatively new application of risk management, quality risk management can benefit from adapting existing theory and practice to pharmaceutical manufacturing.</p>
    

    
    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            <a href="/publication/#2">
              Journal article
            </a>
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publication</div>
          <div class="col-12 col-md-9"><em>Drug Information Journal</em> <strong>41</strong>:353–367</div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="space-below"></div>

    <div class="article-style">
<script src="https://www.gclaycamp.com/publication/2007-perspective-on-qrm/index_files/header-attrs/header-attrs.js"></script>


<p><div class="alert alert-note">
  <div>
    Click the <em>Cite</em> button above to demo the feature to enable visitors to import publication metadata into their reference management software.
  </div>
</div>
</p>
<p><div class="alert alert-note">
  <div>
    Click the <em>Slides</em> button above to demo Academic’s Markdown slides feature.
  </div>
</div>
</p>
<p>Supplementary notes can be added here, including <a href="https://sourcethemes.com/academic/docs/writing-markdown-latex/">code and math</a>.</p>
</div>

    




<div class="article-tags">
  
  <a class="badge badge-light" href="/tag/qrm/">QRM</a>
  
  <a class="badge badge-light" href="/tag/fmea/">FMEA</a>
  
  <a class="badge badge-light" href="/tag/risk-management/">Risk management</a>
  
  <a class="badge badge-light" href="/tag/uncertainty/">uncertainty</a>
  
</div>



<div class="share-box">
  <ul class="share">
    
      
      
      
        
      
      
      
      <li>
        <a href="https://twitter.com/intent/tweet?url=https://www.gclaycamp.com/publication/2007-perspective-on-qrm/&amp;text=Perspective%20on%20Quality%20Risk%20Management%20of%20Pharmaceutical%20Quality" target="_blank" rel="noopener" class="share-btn-twitter" aria-label="twitter">
          <i class="fab fa-twitter"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.facebook.com/sharer.php?u=https://www.gclaycamp.com/publication/2007-perspective-on-qrm/&amp;t=Perspective%20on%20Quality%20Risk%20Management%20of%20Pharmaceutical%20Quality" target="_blank" rel="noopener" class="share-btn-facebook" aria-label="facebook">
          <i class="fab fa-facebook"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="mailto:?subject=Perspective%20on%20Quality%20Risk%20Management%20of%20Pharmaceutical%20Quality&amp;body=https://www.gclaycamp.com/publication/2007-perspective-on-qrm/" target="_blank" rel="noopener" class="share-btn-email" aria-label="envelope">
          <i class="fas fa-envelope"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.linkedin.com/shareArticle?url=https://www.gclaycamp.com/publication/2007-perspective-on-qrm/&amp;title=Perspective%20on%20Quality%20Risk%20Management%20of%20Pharmaceutical%20Quality" target="_blank" rel="noopener" class="share-btn-linkedin" aria-label="linkedin-in">
          <i class="fab fa-linkedin-in"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="whatsapp://send?text=Perspective%20on%20Quality%20Risk%20Management%20of%20Pharmaceutical%20Quality%20https://www.gclaycamp.com/publication/2007-perspective-on-qrm/" target="_blank" rel="noopener" class="share-btn-whatsapp" aria-label="whatsapp">
          <i class="fab fa-whatsapp"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://service.weibo.com/share/share.php?url=https://www.gclaycamp.com/publication/2007-perspective-on-qrm/&amp;title=Perspective%20on%20Quality%20Risk%20Management%20of%20Pharmaceutical%20Quality" target="_blank" rel="noopener" class="share-btn-weibo" aria-label="weibo">
          <i class="fab fa-weibo"></i>
        </a>
      </li>
    
  </ul>
</div>











  
  
    




  
















  </div>
</div>
  </div>

  <div class="page-footer">
    
    
    <div class="container">
      <footer class="site-footer">
  
  
  <hr>
  <p class="powered-by">
      
      Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target="_blank" rel="noopener">Wowchemy</a> — the free, <a href="https://github.com/wowchemy/wowchemy-hugo-modules" target="_blank" rel="noopener">open source</a> website builder that empowers creators.
    
  </p>
  <p class="powered-by">
    (c) 2022 H.G. Claycamp &middot; 

    Made with the <a href="https://cran.r-project.org/" target="_blank" rel="noopener"><i class="fab fa-r-project"></i> </a><a href="https://github.com/rstudio/blogdown" target="_blank" rel="noopener">blogdown</a> package, and the
    <a href="https://sourcethemes.com/academic/" target="_blank" rel="noopener">Academic theme</a> for
    <a href="https://gohugo.io" target="_blank" rel="noopener">Hugo</a>.

    
    <span class="float-right" aria-hidden="true">
      <a href="#" id="back_to_top">
        <span class="button_icon">
          <i class="fas fa-chevron-up fa-2x"></i>
        </span>
      </a>
    </span>
    
  </p>
</footer>

    </div>
    
  </div>

      

    
    <script src="/js/vendor-bundle.min.46271ef31da3f018e9cd1b59300aa265.js"></script>

    
    
    
      

      
      

      

      

    

    
    
    

    
    

    
    
    

    
    

    
    
    
    

    
    

    

    
    
    
    <script id="page-data" type="application/json">{"use_headroom":true}</script>

    
    
      <script src="/js/wowchemy-headroom.c251366b4128fd5e6b046d4c97a62a51.js" type="module"></script>
    
    
    
    
    
    
    
    
    <script src="/en/js/wowchemy.min.0d15e938654f816fb5588d695cc09415.js"></script>

    
    
    
    
    
    
      
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

      <script src="/js/wowchemy-publication.68f8d7090562ca65fc6d3cb3f8f2d2cb.js" type="module"></script>
  <script async defer src="https://buttons.github.io/buttons.js"></script>




    <script src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS_HTML"></script>
    
    <script type="text/x-mathjax-config">
    MathJax.Hub.Config({
        tex2jax: {
            inlineMath: [ ['$','$'], ["\\(","\\)"] ],
            displayMath: [ ['$$','$$'], ["\\[","\\]"] ],
            processEscapes: true,
            processEnvironments: true
        },
        // Center justify equations in code and markdown cells. Elsewhere
        // we use CSS to left justify single line equations in code cells.
        displayAlign: 'center',
        "HTML-CSS": {
            styles: {'.MathJax_Display': {"margin": 0}},
            linebreaks: { automatic: true }
        }
    });
    </script>
    
    


</body>
</html>
